The Creation of Neuroscience
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Welcome to the New Open Access Neurosci
Editorial Welcome to the New Open Access NeuroSci Lucilla Parnetti 1,* , Jonathon Reay 2, Giuseppina Martella 3 , Rosario Francesco Donato 4 , Maurizio Memo 5, Ruth Morona 6, Frank Schubert 7 and Ana Adan 8,9 1 Centro Disturbi della Memoria, Laboratorio di Neurochimica Clinica, Clinica Neurologica, Università di Perugia, 06132 Perugia, Italy 2 Department of Psychology, Teesside University, Victoria, Victoria Rd, Middlesbrough TS3 6DR, UK; [email protected] 3 Laboratory of Neurophysiology and Plasticity, Fondazione Santa Lucia, and University of Rome Tor Vergata, 00143 Rome, Italy; [email protected] 4 Department of Experimental Medicine, University of Perugia, 06132 Perugia, Italy; [email protected] 5 Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy; [email protected] 6 Department of Cell Biology, School of Biology, University Complutense of Madrid, Av. Jose Antonio Novais 12, 28040 Madrid, Spain; [email protected] 7 School of Biological Sciences, University of Portsmouth, Hampshire PO1 2DY, UK; [email protected] 8 Department of Clinical Psychology and Psychobiology, University of Barcelona, 08035 Barcelona, Spain; [email protected] 9 Institute of Neurosciences, University of Barcelona, 08035 Barcelona, Spain * Correspondence: [email protected] Received: 6 August 2020; Accepted: 17 August 2020; Published: 3 September 2020 Message from Editor-in-Chief: Prof. Dr. Lucilla Parnetti With sincere satisfaction and pride, I present to you the new journal, NeuroSci, for which I am pleased to serve as editor-in-chief. To date, the world of neurology has been rapidly advancing, NeuroSci is a cross-disciplinary, open-access journal that offers an opportunity for presentation of novel data in the field of neurology and covers a broad spectrum of areas including neuroanatomy, neurophysiology, neuropharmacology, clinical research and clinical trials, molecular and cellular neuroscience, neuropsychology, cognitive and behavioral neuroscience, and computational neuroscience. -
"A Sixty-Year Evolution of Biochemistry at Mcgill University"
Article "A Sixty-Year Evolution of Biochemistry at McGill University" Rose Johstone Scientia Canadensis: Canadian Journal of the History of Science, Technology and Medicine / Scientia Canadensis : revue canadienne d'histoire des sciences, des techniques et de la médecine , vol. 27, 2003, p. 27-83. Pour citer cet article, utiliser l'information suivante : URI: http://id.erudit.org/iderudit/800458ar DOI: 10.7202/800458ar Note : les règles d'écriture des références bibliographiques peuvent varier selon les différents domaines du savoir. Ce document est protégé par la loi sur le droit d'auteur. L'utilisation des services d'Érudit (y compris la reproduction) est assujettie à sa politique d'utilisation que vous pouvez consulter à l'URI https://apropos.erudit.org/fr/usagers/politique-dutilisation/ Érudit est un consortium interuniversitaire sans but lucratif composé de l'Université de Montréal, l'Université Laval et l'Université du Québec à Montréal. Il a pour mission la promotion et la valorisation de la recherche. Érudit offre des services d'édition numérique de documents scientifiques depuis 1998. Pour communiquer avec les responsables d'Érudit : [email protected] Document téléchargé le 14 février 2017 07:44 A Sixty-Year Evolution of Biochemistry at McGill University ROSE JOHNSTONE' Résumé: Le département de biochimie de l'université McGill a ouvert ses portes près d'un siècle après la création de l'école de médecine. Les racines du département, toutefois, plongent jusqu'au tout début de l'école de médecine en 1829. Parce que plusieurs membres fondateurs de l'école de médecine reçurent leur formation à Edimbourg, le programme de formation médicale porte la marque de l'école d'Edimbourg — particulièrement l'accent placé sur la formation en chimie et la recherche fondamen• tale. -
BRAIN Neuroethics Working Group Meeting
Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Neuroethics Working Group (NEWG) Meeting January 26th, 2021 On January 26th, 2021, the National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Neuroethics Working Group (NEWG) met virtually to discuss emerging ethics themes in the BRAIN portfolio and potential future workshop topics, and revisited neuroethics themes in the BRAIN 2.0 reports. In opening remarks, John Ngai, PhD, Director of the NIH BRAIN Initiative, emphasized the importance of continuing to work towards equity, in general and in the neuroethics space. He also reminded participants of the joint session with the Multi-Council Working Group (MCWG) and NEWG, which took place the following day. Next, Saskia Hendriks, MD, PhD, Faculty in the NIH Bioethics Department and National Institute of Neurological Disorders and Stroke (NINDS) Neuroethics Consultant, presented key findings from an analysis on emerging neuroethical considerations in BRAIN grants awarded during fiscal year 2020. Dr. Hendriks summarized 12 themes identified by the analysis, which fell into two broad groups of potential ethical challenges: conducting research ethically; and the implications of research, tools, and technologies on individuals, groups, and society. The NEWG valued these findings, recognizing that the themes were consistent with concurrent discussions of neuroethics priorities for BRAIN. Participants also considered increasing funding opportunity outreach efforts to neuroscientists interested in partnering with neuroethicists. Further, the group acknowledged the need to raise awareness about the value of integrating neuroethics into neuroscience research, potentially by hosting a workshop on identifying ways to facilitate this integration. Henry (Hank) T. Greely, JD, Director of Law and Biosciences at Stanford University and co-chair of the NEWG, led a discussion on potential future NEWG workshop topics for the next phase of the NIH BRAIN Initiative. -
Richard Llewelyn-Davies and the Architect's Dilemma."
The Richard Llewciy11-Davies Memorial Lectures in ENVIRONMENT AND SOCIETY March 3, 1985-at the Institute for Advanced Study The J/ictoria11 City: Images and Realities Asa Briggs Provost of Worcester College University of Oxford November 17, 1986--at the University of London The Nuffield Planning Inquiry Brian Flo\vers Vice-Chancellor University of London October 27, 1987-at the Institute for Advanced Study Richard Llewcly11-Davics and the Architect's Dilemma N ocl Annan Vice-Chancellor Erncritus University of London PREFACE The Richard Llewelyn-Davies Memorial Lectures in "Environ ment and Society" were established to honor the memory of an architect distinguished in the fields of contemporary architectural, urban and environmental planning. Born in Wales in 1912, Richard Llewelyn-Davies was educated at Trinity College, Cambridge, !'Ecole des Beaux Arts in Paris and the Architectural Association in London. In 1960 he began a fif teen-year association with University College of the University of London as Professor of Architecture, Professor of Town Planning, Head of the Bartlett School of Architecture and Dean of the School of Environmental Studies. He became, in 1967, the initial chair man of Britain's Centre for Environmental Studies, one of the world's leading research organizations on urbanism, and held that post for the rest of his life. He combined his academic career with professional practice in England, the Middle East, Africa, Paki stan, North and South America. In the fall of 1980, the year before he died, Richard Llewelyn Davies came to the Institute for Advanced Study. He influenced us in many ways, from a reorientation of the seating arrangement in the seminar room improving discussion and exchange, to the per manent implantation of an environmental sensibility. -
Cambridge's 92 Nobel Prize Winners Part 2 - 1951 to 1974: from Crick and Watson to Dorothy Hodgkin
Cambridge's 92 Nobel Prize winners part 2 - 1951 to 1974: from Crick and Watson to Dorothy Hodgkin By Cambridge News | Posted: January 18, 2016 By Adam Care The News has been rounding up all of Cambridge's 92 Nobel Laureates, celebrating over 100 years of scientific and social innovation. ADVERTISING In this installment we move from 1951 to 1974, a period which saw a host of dramatic breakthroughs, in biology, atomic science, the discovery of pulsars and theories of global trade. It's also a period which saw The Eagle pub come to national prominence and the appearance of the first female name in Cambridge University's long Nobel history. The Gender Pay Gap Sale! Shop Online to get 13.9% off From 8 - 11 March, get 13.9% off 1,000s of items, it highlights the pay gap between men & women in the UK. Shop the Gender Pay Gap Sale – now. Promoted by Oxfam 1. 1951 Ernest Walton, Trinity College: Nobel Prize in Physics, for using accelerated particles to study atomic nuclei 2. 1951 John Cockcroft, St John's / Churchill Colleges: Nobel Prize in Physics, for using accelerated particles to study atomic nuclei Walton and Cockcroft shared the 1951 physics prize after they famously 'split the atom' in Cambridge 1932, ushering in the nuclear age with their particle accelerator, the Cockcroft-Walton generator. In later years Walton returned to his native Ireland, as a fellow of Trinity College Dublin, while in 1951 Cockcroft became the first master of Churchill College, where he died 16 years later. 3. 1952 Archer Martin, Peterhouse: Nobel Prize in Chemistry, for developing partition chromatography 4. -
Obama Administration Proposes Over $434 Million in Funding for the BRAIN Initiative
Obama Administration Proposes Over $434 Million in Funding for the BRAIN Initiative “Last year, I launched the BRAIN Initiative to help unlock the mysteries of the brain, to improve our treatment of conditions like Alzheimer’s and autism and to deepen our understanding of how we think, learn and remember. I’m pleased to announce new steps that my Administration is taking to support this critical research, and I’m heartened to see so many private, philanthropic, and academic institutions joining this effort.” - President Barack Obama September 2014 Since its launch in April 2013, the President’s BRAIN Initiative® - Brain Research through Advancing Innovative Neurotechnologies – has grown to include investments from five Federal agencies: the Defense Advanced Research Projects Agency (DARPA), the National Institutes of Health (NIH), the National Science Foundation (NSF), Intelligence Advanced Research Projects Activity (IARPA), and the Food and Drug Administration (FDA). Federal agencies are supporting the initiative by investing in promising research projects aimed at revolutionizing our understanding of the human brain, developing novel technologies, and supporting further research and development in neurotechnology. The President’s 2017 Budget also proposes funding for the Department of Energy (DOE) to join DARPA, NIH, NSF, IARPA, and FDA in advancing the goals of the BRAIN Initiative. Major foundations, private research institutions, and companies including the Howard Hughes Medical Institute, Allen Institute for Brain Science, the Kavli Foundation, the Simons Foundation, GE, GlaxoSmithKline, as well as patient advocacy organizations and universities, have committed over $500 million to the BRAIN Initiative. There are many opportunities for others across sectors to play a role in this historic initiative through new and expanded commitments to advance the BRAIN Initiative. -
Introduction and Historical Perspective
Chapter 1 Introduction and Historical Perspective “ Nothing in biology makes sense except in the light of evolution. ” modified by the developmental history of the organism, Theodosius Dobzhansky its physiology – from cellular to systems levels – and by the social and physical environment. Finally, behaviors are shaped through evolutionary forces of natural selection OVERVIEW that optimize survival and reproduction ( Figure 1.1 ). Truly, the study of behavior provides us with a window through Behavioral genetics aims to understand the genetic which we can view much of biology. mechanisms that enable the nervous system to direct Understanding behaviors requires a multidisciplinary appropriate interactions between organisms and their perspective, with regulation of gene expression at its core. social and physical environments. Early scientific The emerging field of behavioral genetics is still taking explorations of animal behavior defined the fields shape and its boundaries are still being defined. Behavioral of experimental psychology and classical ethology. genetics has evolved through the merger of experimental Behavioral genetics has emerged as an interdisciplin- psychology and classical ethology with evolutionary biol- ary science at the interface of experimental psychology, ogy and genetics, and also incorporates aspects of neuro- classical ethology, genetics, and neuroscience. This science ( Figure 1.2 ). To gain a perspective on the current chapter provides a brief overview of the emergence of definition of this field, it is helpful -
Oligodendrocytes in Development, Myelin Generation and Beyond
cells Review Oligodendrocytes in Development, Myelin Generation and Beyond Sarah Kuhn y, Laura Gritti y, Daniel Crooks and Yvonne Dombrowski * Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast BT9 7BL, UK; [email protected] (S.K.); [email protected] (L.G.); [email protected] (D.C.) * Correspondence: [email protected]; Tel.: +0044-28-9097-6127 These authors contributed equally. y Received: 15 October 2019; Accepted: 7 November 2019; Published: 12 November 2019 Abstract: Oligodendrocytes are the myelinating cells of the central nervous system (CNS) that are generated from oligodendrocyte progenitor cells (OPC). OPC are distributed throughout the CNS and represent a pool of migratory and proliferative adult progenitor cells that can differentiate into oligodendrocytes. The central function of oligodendrocytes is to generate myelin, which is an extended membrane from the cell that wraps tightly around axons. Due to this energy consuming process and the associated high metabolic turnover oligodendrocytes are vulnerable to cytotoxic and excitotoxic factors. Oligodendrocyte pathology is therefore evident in a range of disorders including multiple sclerosis, schizophrenia and Alzheimer’s disease. Deceased oligodendrocytes can be replenished from the adult OPC pool and lost myelin can be regenerated during remyelination, which can prevent axonal degeneration and can restore function. Cell population studies have recently identified novel immunomodulatory functions of oligodendrocytes, the implications of which, e.g., for diseases with primary oligodendrocyte pathology, are not yet clear. Here, we review the journey of oligodendrocytes from the embryonic stage to their role in homeostasis and their fate in disease. We will also discuss the most common models used to study oligodendrocytes and describe newly discovered functions of oligodendrocytes. -
The Birth of Information in the Brain: Edgar Adrian and the Vacuum Tube,” Science in Context 28: 31-52
Garson, J. (2015) “The Birth of Information in the Brain: Edgar Adrian and the Vacuum Tube,” Science in Context 28: 31-52. Preprint (not copyedited or formatted) Please use DOI when citing or quoting: https://doi- org.proxy.wexler.hunter.cuny.edu/10.1017/S0269889714000313 The Birth of Information in the Brain: Edgar Adrian and the Vacuum Tube Word Count: 10, 418 Abstract: As historian Henning Schmidgen notes, the scientific study of the nervous system would have been ‘unthinkable’ without the industrialization of communication in the 1830s. Historians have investigated extensively the way nerve physiologists have borrowed concepts and tools from the field of communications, particularly regarding the nineteenth-century work of figures like Helmholtz and in the American Cold War Era. The following focuses specifically on the interwar research of the Cambridge physiologist Edgar Douglas Adrian, and on the technology that led to his Nobel-Prize- winning research, the thermionic vacuum tube. Many countries used the vacuum tube during the war for the purpose of amplifying and intercepting coded messages. These events provided a context for Adrian’s evolving understanding of the nerve fiber in the 1920s. In particular, they provide the background for Adrian’s transition around 1926 to describing the nerve impulse in terms of “information,” “messages,” “signals,” or even “codes,” and for translating the basic principles of the nerve, such as the all-or-none principle and adaptation, into such an “informational” context. The following also places Adrian’s research in the broader context of the changing relationship between science and technology, and between physics and physiology, in the first few decades of the twentieth century. -
Glutamatergic Synaptic Plasticity in the Mesocorticolimbic System in Addiction
REVIEW ARTICLE published: 20 January 2015 CELLULAR NEUROSCIENCE doi: 10.3389/fncel.2014.00466 Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction Aile N. van Huijstee and Huibert D. Mansvelder * Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University Amsterdam, Amsterdam, Netherlands Edited by: Addictive drugs remodel the brain’s reward circuitry, the mesocorticolimbic dopamine (DA) Arianna Maffei, SUNY Stony Brook, system, by inducing widespread adaptations of glutamatergic synapses. This drug-induced USA synaptic plasticity is thought to contribute to both the development and the persistence Reviewed by: Christian Luscher, Geneva of addiction. This review highlights the synaptic modifications that are induced by in vivo University Hospital, University of exposure to addictive drugs and describes how these drug-induced synaptic changes may Geneva, Switzerland contribute to the different components of addictive behavior, such as compulsive drug Fereshteh S. Nugent, Uniformed use despite negative consequences and relapse. Initially, exposure to an addictive drug Services University, USA induces synaptic changes in the ventral tegmental area (VTA). This drug-induced synaptic *Correspondence: Huibert D. Mansvelder, Department potentiation in the VTA subsequently triggers synaptic changes in downstream areas of of Integrative Neurophysiology, the mesocorticolimbic system, such as the nucleus accumbens (NAc) and the prefrontal Center -
Nernst Potentials and Membrane Potential Changes
UNDERSTANDING MEMBRANE POTENTIAL CHANGES IN TERMS OF NERNST POTENTIALS: For seeing how a change in conductance to ions affects the membrane potential, follow these steps: 1. Make a graph with membrane potential on the vertical axis (-100 to +55) and time on the horizontal axis. 2. Draw dashed lines indicating the standard Nernst potential (equilibrium potential) for each ion: Na+ = +55 mV, K+ = -90mV, Cl- = -65 mV. 3. Draw lines below the horizontal axis showing the increased conductance to individual ions. 4. Start plotting the membrane potential on the left. Most graphs will start at resting potential (-70 mV) 5. When current injection (Stim) is present, move the membrane potential upward to Firing threshold. 6. For the time during which membrane conductance to a particular ion increases, move the membrane potential toward the Nernst potential for that ion. 7. During the time when conductance to a particular ion decreases, move the membrane potential away from the Nernst potential of that ion, toward a position which averages the conductances of the other ions. 8. When conductances return to their original value, membrane potential will go to its starting value. +55mV ACTION POTENTIAL SYNAPTIC POTENTIALS 0mV Membrane potential Firing threshold Firing threshold -65mV -90mV Time Time Na+ K+ Conductances Stim CHANGES IN MEMBRANE POTENTIAL ALLOW NEURONS TO COMMUNICATE The membrane potential of a neuron can be measured with an intracellular electrode. This 1 provides a measurement of the voltage difference between the inside of the cell and the outside. When there is no external input, the membrane potential will usually remain at a value called the resting potential. -
Michael M. Merzenich
Michael M. Merzenich BORN: Lebanon, Oregon May 15, 1942 EDUCATION: Public Schools, Lebanon, Oregon (1924–1935) University of Portland (Oregon), B.S. (1965) Johns Hopkins University, Ph.D. (1968) University of Wisconsin Postdoctoral Fellow (1968–1971) APPOINTMENTS: Assistant and Associate Professor, University of California at San Francisco (1971–1980) Francis A. Sooy Professor, University of California at San Francisco (1981–2008) President and CEO, Scientifi c Learning Corporation (1995–1996) Chief Scientifi c Offi cer, Scientifi c Learning Corporation (1996–2003) Chief Scientifi c Offi cer, Posit Science Corporation (2004–present) President and CEO, Brain Plasticity Institute (2008–present) HONORS AND AWARDS (SELECTED): Cortical Discoverer Prize, Cajal Club (1994) IPSEN Prize (Paris, 1997) Zotterman Prize (Stockholm, 1998) Craik Prize (Cambridge, 1998) National Academy of Sciences, U.S.A. (1999) Lashley Award, American Philosophical Society (1999) Thomas Edison Prize (Menlo Park, NJ, 2000) American Psychological Society Distinguished Scientifi c Contribution Award (2001) Zülch Prize, Max-Planck Society (2002) Genius Award, Cure Autism Now (2002) Purkinje Medal, Czech Academy (2003) Neurotechnologist of the Year (2006) Institute of Medicine (2008) Michael M. Merzenich has conducted studies defi ning the functional organization of the auditory and somatosensory nervous systems. Initial models of a commercially successful cochlear implant (now distributed by Boston Scientifi c) were developed in his laboratory. Seminal research on cortical plasticity conducted in his laboratory contributed to our current understanding of the phenomenology of brain plasticity across the human lifetime. Merzenich extended this research into the commercial world by co-founding three brain plasticity-based therapeutic software companies (Scientifi c Learning, Posit Science, and Brain Plasticity Institute).